Drugs / Autologous Human C-Kit CSCs II
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02503280 | Mar 2025 → Mar 2030 | left ventricular failure, myocardial infarction | Joshua M Hare | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Human C-Kit CSCs II | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02503280 ↗ |
| Known as | Autologous Human C-Kit Cardiac Stem Cells (CSCs) II | “Autologous Human C-Kit Cardiac Stem Cells (CSCs) II” NCT02503280 ↗ |
| Route | Other | “Transendocardial Injection of Autologous Human Cells” NCT02503280 ↗ |